Sana Biotechnology, Inc. (NASDAQ: SANA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SANA BIOTECHNOLOGY, INC.

Sana Biotechnology, Inc. (NASDAQ: SANA)
Listen to this Section


$3.02
-0.1050 ( -3.37% ) 2.2M

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

Market Data


Open $3.02
Previous Close $3.12
Volume 2.2M
Market Cap $868.27M
Day Range $3.01 - $3.24
52 Week Range $2.26 - $6.55
Shares Outstanding 278.29M
Change % -3.37%
Net Change ▼ -0.1050
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -65,199.00

Date Type Amount Purchased Purchaser
2024-07-08 Sale -4911.00 Bishop Hans Edgar
2024-06-07 Sale -54278.00 REICIN ALISE
2024-06-07 Sale -54278.00 Wilderotter Mary Agnes
2024-06-07 Sale -54278.00 NELSEN ROBERT
2024-06-07 Sale -54278.00 Seitz Michelle
2024-06-07 Sale -54278.00 Mulligan Richard
2024-06-07 Sale -54278.00 Bilenker Joshua H.
2024-06-07 Sale -54278.00 Yang Patrick Y
2024-06-07 Sale -54278.00 Bishop Hans Edgar
2024-06-07 Sale -54278.00 Cole Douglas G.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 79 Nov 06, 2025
8-k 8K-related 11 Nov 06, 2025
4 Insider transactions 1 Oct 07, 2025
8-k 8K-related 10 Sep 05, 2025
8-k 8K-related 10 Aug 29, 2025
8-k 8K-related 11 Aug 11, 2025
10-q Quarterly Reports 80 Aug 11, 2025
8-k 8K-related 19 Aug 07, 2025
8-k 8K-related 12 Aug 06, 2025
4 Insider transactions 1 Jul 08, 2025

Latest News


× Before browsing our site, please accept our cookies policy